Hong Kong – Paul Hastings, a leading global law firm, announced today that the firm advised the joint sponsors and the joint global coordinators on the global offering and listing of Dingdang Health Technology Group Ltd. on the Main Board of the Hong Kong Stock Exchange.

China International Capital Corporation Hong Kong Securities Limited and CMB International Capital Limited (in no particular order) acted as the joint sponsors and the joint global coordinators.

Dingdang Health Technology is a service provider in providing express digital healthcare services in China. The company has been facilitating the transformation and upgrade of China’s healthcare industry by on-demand pharmaceutical retail and medical consultation, primarily with online-to-offline solutions, including operations related to its online platforms, offline smart pharmacies and express delivery service.

The Paul Hastings team was led by Raymond Li, global partner and chair of Greater China, and corporate partners Vincent Wang, and Chaobo Fan, with support from of counsel Eric Wong, associate Berton Wang, legal managers Ruby Chong, Alex Chan, and Flora Huang, China associates Irina He, Guozhen Wang and Felix Chen, and China advisors Lillian Li, Yufei Mo and Jingyi Cao.

About Paul Hastings

With widely recognized elite teams in finance, mergers & acquisitions, private equity, restructuring and special situations, litigation, employment and real estate, Paul Hastings is a premier law firm providing superior intellectual capital and execution globally to the world’s leading investment banks, asset managers and corporations.